期刊名称：FERTILITY AND STERILITY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. The journal publishes juried original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, urology, andrology, physiology, immunology, genetics, contraception, and menopause. Fertility and Sterility® encourages and supports meaningful basic and clinical research, and facilitates and promotes excellence in professional education, in the field of reproductive medicine.
Instructions to Authors
Official Journal of the American Society for Reproductive Medicine, Society for Reproductive Endocrinology and Infertility, Society of Reproductive Surgeons, Society for Assisted Reproductive Technology, Society for Male Reproduction and Urology, and Pacific Coast Reproductive Society
Official Journal of the American Society for Reproductive Medicine, Society for Reproductive Endocrinology and Infertility, Society of Reproductive Surgeons, Society for Assisted Reproductive Technology, Society for Male Reproduction and Urology, Pacific Coast Reproductive Society, and the Canadian Fertility and Andrology Society
Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders as well as issues related to women's health. The journal's mission is to: publish peer-reviewed original scientific articles in clinical and laboratory research relevant to reproductive endocrinology, infertility, developmental biology, urology, andrology, physiology, immunology, genetics, contraception, and menopause that will support evidence-based practice and opinions in reproductive science and clinical medicine; publish timely review articles; editorials, committee opinions and practice guidelines that act as an authoritative resource and define professionalism as well as set high ethical standards for clinical reproductive medicine and basic reproductive science.
PERMISSION REQUESTS
Permission requests are handled by Elsevier Inc., Philadelphia. Please contact the permissions editor at: healthpermissions@elsevier.com.
PUBMED CENTRAL POLICY
Manuscripts submitted that acknowledge NIH grant support will automatically be submitted to Pubmed Central and available to all in an open access format beginning one year from the date of publication in a print issue.
INSTRUCTIONS FOR AUTHORS
Only those manuscripts which are original, have not been published elsewhere, and are not currently being considered for inclusion in another publication will be considered for publication in Fertility and Sterility®. Authors are advised to keep a copy of all manuscripts submitted. All manuscripts (meaning all submission items, including all text, tables, artwork, cover letters, conflict of interest disclosures, and any other required materials) must be submitted to the Fertility and Sterility® Editorial Office through the Elsevier Editorial System (EES) website for this journal at  http://ees.elsevier.com/fns. Do not mail, email, or fax your manuscripts to the editorial office. In an accompanying cover letter, authors shouldstate that the material contained in the manuscript has not been published, has not been submitted, or is not being submitted elsewhere for publication. Include the names and contact information (phone, address, email, fax), of three reviewers who would be qualified to review your manuscript.
All manuscripts will be evaluated by peer reviewers who will remain anonymous. These peer reviews may or may not be the reviewers suggested by the author, and selection of the peer reviewers is in the sole discretion of the Fertility and Sterility® Editorial Office. The editors do not disclose any information about a manuscript submitted for review or its contents to anyone other than the reviewers. If revisions are required, authors are asked to return the revised manuscripts within 60 days. Please notify the editorial office if additional time is needed or if you choose not to submit a revision.
Word limits are 3500 words for Modern Trends and other review articles, 2500 words for clinical articles and reproductive biology, and 1500 words for case reports, correspondences, and techniques and instrumentation. The word limit does not include the running title, title page, capsule, or abstract.
If you wish, you may include additional information (such as an expanded materials and methods section, or additional figures) as supplemental material. This supplemental material will be published in the online version only, and will be referenced in the print version. Please indicate in your cover letter which sections are intended to be supplemental material and submit the supplemental material in a separate file.
Submission items include a cover letter, manuscript (including the running title, title page, capsule, structured abstract, manuscript text, references, and table/figure legends), tables, figures, and conflict of interest disclosure forms. The cover letter should identify the person (with the address, telephone number, fax number, and e-mail) responsible for correspondence concerning the manuscript. Revised manuscripts should also be accompanied by a unique file (separate from the covering letter) with responses to reviewers' comments. The preferred order of files is as follows: cover letter, revision notes (revised manuscript only), manuscript file(s), table(s), figure(s), and disclosure forms. Files should be labeled with appropriate and descriptive file names (e.g., SmithText.doc, Fig1.eps, Table 3.doc). Upload each table and figure as individual files separate from the manuscript. Do not import figures or tables into the text document. Your manuscript should be in Word (doc) format. Tables may be inWord (doc) or Excel (xls) format. Figures should be in tiff, eps, ppt, or doc format. Do not submit your manuscript, tables, or figures as pdf files. Disclosure forms may be submitted in any format. Complete instructions for electronic artwork submission can be found at http://www.elsevier.com/wps/find/authorsview.authors/authorartworkinstructions.
All correspondence regarding submitted manuscripts will be handled via e-mail through EES. Send all other correspondence to:
Alan H. DeCherney, M.D.
Editor-in-Chief, Fertility and Sterility®
American Society for Reproductive Medicine (ASRM)
1209 Montgomery Highway
Birmingham, AL 35216
P: 205-978-5000 x139
F: 205-978-5012
E: fertstert@asrm.org
Prior to publication, the author(s) must sign and return the "Assignment of Copyright and Financial Subsidy Disclosure Form.' This form will be supplied by the publisher. The manuscript, when published, will become the property of the journal and the copyright interest in the manuscript will be registered in the name of the publisher, the American Society of Reproductive Medicine. No responsibility is assumed by the Editor, the American Society for Reproductive Medicine, or the Publisher for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein.
PREPARATION OF MANUSCRIPTS
Fertility and Sterility® follows the "Uniform Requirements for Manuscripts Submitted to Biomedical Journals.' Manuscripts must be typed double-spaced with margins of at least 25 mm (1 in).
Manuscripts will not be acceptable for publication unless they meet the following editorial requirements. Each of the following manuscript components should begin on a new page in the following sequence.
Page 1, Running Title: a maximum of 40 spaces and letters;
Page 2, Title Page: provide the full title, full name, highest awarded academic degree, and institutional affiliation of each author. All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the coauthors. Each author should have participated sufficiently in the work to take public responsibility for the content. In general, no more than eight authors is considered appropriate; if more are necessary, explain in your cover letter how each author contributed to the research. Indicate a corresponding author for reprints, and give full contact information. Also include statements disclosing any potential conflicts of interest and acknowledging any financial support (grant number, institution, and location);
Page 3, Capsule: a 30-word summary of the abstract, which will be published in the Table of Contents. The final conclusions should be described;
Page 4, Structured Abstract and Key Words: The abstract should present the study objective, design, setting, patients, interventions, main outcome measure(s), results, and conclusions. The abstract should also emphasize new and important aspects of the study or observation and tract may not exceed 200 words. Below the abstract provide 3 to 10 key words or short phrases that will assist indexers in cross-indexing the article. For a correspondence, provide a two-sentence narrative abstract instead of a structured abstract.
Begin your manuscript on Page 5: Manuscripts should be no longer than 2500 words and include a maximum of 4 total tables and figures. The following components should be identified: Introduction, Materials and Methods, Results, Discussion, Acknowledgments, References, and Figure Legends. Begin references on a new page.
Units of Measurement. Measurements of length, height, weight, and volume should be reported in metric units (meter, kilogram, or liter) or their decimal multiples. Temperatures should be given in degrees Celsius.All hematologic and clinical-chemistrymeasurements should be reported in the metric systemin conventional units. If values are represented in SI units, the conversion factor must be included.
Statistical Validation. When describing statistical analyses that have been performed, tests that were used to evaluate a specific data set must be clearly indicated. When data are presented in tables, indicate the statistical test(s) that was used to evaluate the data with a footnote. When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Define statistical terms, abbreviations, and most symbols.
Abbreviations and Symbols. Use only standard abbreviations. Define all abbreviations on first usage, except universal abbreviations; see the Manuscript Format file (found at http://ees.elsevier.com/fns, under "Author Files") for a list of universal abbreviations.Acknowledgments. Persons who have contributed intellectually to the paper but whose contributions do not justify authorship may be named and their function or contribution described, e.g. "scientific adviser," "data collections," or "participation in clinical trial." Such persons must have given their permission to be named. Authors are responsible for obtaining written permission from the persons acknowledged by name, because readers may infer their endorsement of the data and conclusions.
References. Number references consecutively in the order in which they are first mentioned in the text. References appearing for the first time in tables and figures must be numbered in sequence with those cited in the text where the table or figure is mentioned. References are identified by Arabic numerals in parentheses.
Unpublished observations, and personal communications may not be used as references, although references to written, not oral communications may be inserted (in parentheses) in the text. Abstracts published in a citable journal may be cited. To cite a paper accepted but not yet published, state "In Press" in place of the volume information, and include the paper's DOI number. Information from manuscripts submitted but not yet accepted should be cited in the text as "unpublished observations" (in parentheses). If author's(s') own papers are quoted as "In press" in the reference list, two copies of such papers must be provided so that the referees can properly assess the paper submitted. References must be verified by the author(s) against the original documents. The titles of journals should be abbreviated according to the style used in Index Medicus. List all authors in an article, but if the number exceeds six, give six followed by et al.
Examples of References
Journal Article
1. Flisser E, Scott RT, Copperman AT. Patient-friendly IVF: how should it be defined?. Fertil Steril 2007;88:547-9.
Books
2. Colson JH, Armour WJ. Sports injuries and their treatment. 2nd rev. ed. London: S. Paul, 1986.
3. Diener HC, Wilkinson M, eds. Drug-induced headache. New York: Springer-Verlag, 1988.
4. Weinstein L, Swartz MN. Pathologic properties of invading microorganisms. In: Sodeman WA Jr, Sodeman WA, eds. Pathologic physiology: mechanisms of disease. Vol. 1. Philadelphia: WB Saunders, 1974:457-72.
Letter
6. Stein A. [letter]. Fertil Steril 2007;88:756.
In Press
7. Lillywhite HB, Donald JA. Pulmonary blood flow regulation in an aquatic snake. Fertil Steril, In Press, DOI: 10.1016/j.fertnstert. 2007.06.043.
Website
8. American Society for Reproductive Medicine. Headlines in reproductive medicine. Available at: http://www.asrm.org/headlines/. Accessed May 6, 2010.
Tables. Should be typed double-spaced on separate pages, and they should be titled and numbered in Arabic numerals (not Roman numerals) in the order of their first citation in the text. Do not submit tables as photographs. Give each column a short heading. Place explanatory matter in footnotes, not in the heading. For footnotes use the following symbols, in this sequence: a, b, c, d, e, f. Do not use internal horizontal and vertical rules.
Illustrations. Figures should be professionally drawn and photographed; freehand or typewritten lettering is unacceptable. Each figure should be submitted in a separate tiff, eps, ppt, or doc file, at a resolution of 300 dpi for photos and 1200 dpi for line art. Lettering and identifying marks should be clear, and type size should be consistent on each figure. Capital letters should be used for specific areas of identification in a figure. Symbols, lettering, and numbering should be distinctly recognizable so that when the figure is reduced for publication each item will still be legible. Titles and detailed explanations belong in the legends for illustrations, not on the illustrations themselves. Slides are not acceptable. There is a page charge for color photographs, with the exception of color graphs and color charts. There is a maximum of one illustration and/or table for every 600 words (approximately 3 typewritten pages). Additional tables or figures may be submitted as supplemental material, and will be published in the online version only.
Legends. Do not include figure legends in the same file as the figure; place them instead on a page at the end of your manuscript.
Permissions. Materials taken from other sources must be accompanied by a written statement from the copyright holder giving permission to the American Society for Reproductive Medicine for reproduction in Fertility and Sterility®.
Video Clips/Animation. For information about includingmedia files, such as video clips or animations, please refer to the following: http://authors.elsevier.com/ArtworkInstructions.html?dc?AI43 / pdf version.
Tracking Your Manuscript. Authors can track the progress of a manuscript on the journal's website (www.ees.elsevier.com/fns) by logging into their accounts with their user name and password.Online publication. Articles that are accepted for publication are now listed in the "Articles In Press" section of the journal's website (www.fertstert.org).
Errata. Errata are published in the journal, but if an erratum represents the author's failure to pick up a mistake on the galley proofs, this will be noted in the erratum. A corrigendum may also be published, in which the error and correction will be published together.
INSTITUTIONAL REVIEW BOARD/INSTITUTIONAL ANIMAL CARE AND USE COMMITTEE (IACUC) APPROVAL A written statement must be attached with the original correspondence indicating whether or not Institutional Review Board (IRB) approval was obtained or equivalent guidelines followed in accordance with the Helsinki Declaration of 1975 on human experimentation; if not, an explanation must be provided. In addition, a statement of IRB status (approved, waived, or other) must be included in the Materials and Methods section of your manuscript. Similarly, a written statement confirming approval by appropriate IACUC must be included for research involving animals. Any manuscript submitted without appropriate IRB or IACUC approval will not be reviewed and will be returned to the authors.
CLINICAL TRIAL REGISTRATION
All clinical trials submitted for publication must show proof of clinical trail registration in the NIH Protocol Registration System. This is in keeping with policies adopted by the International Committee of Medical Journal Editors (ICMJE). In addition, the FDA now requires by law that all clinical trials of an investigational new drug be registered. For more information and to register a trial, see http://prsinfo.clinicaltrials.gov.
CONFLICT OF INTEREST
Fertility and Sterility® now uses the ICMJE Uniform Disclosure Form for Potential Conflicts of Interest. Each author must complete and sign the form, which can be found at http://www.icmje.org. Please include these forms with your original submission. All authors must disclose any commercial interest, financial interest, and/or other relationship with manufacturers of pharmaceuticals, laboratory supplies, and/or medical devices and with commercial providers of medically related services. All relationships must be disclosed. All non-FDA-approved uses of products must be clearly identified.
Commercial interest is defined as any proprietary entity producing, marketing, re-selling, distributing, or otherwise participating in or profiting from the distribution, promotion, or sale of health care goods or services consumed by, or used on, patients.
Financial interests/relationships are those in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits usually are associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received or expected. This includes any financial relationships within the last twelve months, as well as known financial relationships of your spouse or partner.
Include all disclosures on the title page of your manuscript, as well.
ETHICS IN PUBLISHING
Authors
Conditions of Authorship Authors should have made significant conceptual, intellectual, experimental, and analytical contributions to the research, as well as having participated in writing and revising the manuscript.
Each author should have participated sufficiently in the work to take public responsibility for its content.
Honorary authorship (i.e., not adhering to the conditions of authorship and nonetheless being granted authorship) is not permitted.
Responsibilities of Authors Authors must describe the research in sufficient detail such that others could repeat it.
Written, informed consent under protocols approved by an institutional or local review board or approved animal protocols are essential if the research involves human or animal subjects, respectively. This information should be stated in the manuscript and the protocol number or exempt status of approved protocols should be stated in the manuscript at the time of submission for review.
Authors of clinical trials are required to register their trial with one of the ICMJE-recognized trial registries.
Selective reporting of data is inappropriate, especially if unreported data are in disagreement with the findings of the selectively reported data. In accordance with the ICJME, the ASRM supports publication of negative studies.
Authors should cite publications in the literature that are relevant to the uniqueness of the research and should include publications by others as well as of their own research group.
Previous publication of a preliminary report on the data is permissible if this is stated clearly in a footnote in the manuscript.
Scientific Misconduct Definition: The DHHS Office of Research Integrity defines plagiarism, fabrication, and falsification. The ASRM accepts these definitions and considers them to constitute scientific misconduct. Additional unethical behavior that comprises scientific misconduct includes: submission of results from animal or clinical research that was conducted without appropriate approval and written, informed consent; duplicate publication; and honorary authorship.
Research misconduct occurs when results are falsified, fabricated or plagiarized. The actions are willful or intentional in research misconduct, although the actual definition of misconduct varies somewhat by country. This can occur at various times during the process of proposing, performing or reviewing research.
- Fabrication: Data, results or recording or reporting information that does not exist.
- Falsification: Changing research materials, equipment or processes; omission of data or results. As a consequence, the research is not accurately represented in the research records.
- Plagiarism: Using another person's words, ideas, results, and processes without giving credit to them constitutes plagiarism. Self-plagiarism can include multiple publications of essentially the same manuscript or data in different journals, books, or other publications (see "Duplicate Publication" below).
Plagiarism includes the theft of intellectual property, ideas or methods such as the use of information gained by personal communication or during a grant or manuscript review. Plagiarism also includes the direct textual copying of your own or another person's work. Direct copying of 100-250 words or more constitutes plagiarism. Authorship disputes are not included in this definition. Citation plagiarism is the failure to credit others with prior discoveries. Differences of opinion or honest errors do not constitute misconduct.
Submission without animal or human subjects' oversight approvals. Any manuscript submitted without proof of animal or human subjects approval by institutional or local IRBs will not be reviewed and will be returned to the authors. Duplicate publication. Duplicate publication can take several forms:
- Duplicate Publication with other journals. On occasion ASRM journals may decide to publish an article simultaneously with another journal, e.g., with consensus statements from consensus conferences. Such intention on the part of the Editor-In-Chief should be discussed with the Publications Committee immediately after the two journals have had a discussion so that Publications Committee members can assess the appropriateness of such joint publications and approve or disapprove.
- Publication of identical data. The ASRM considers that disclosure, citing the original publication and obtaining permission are essential. Without all of these, publication of identical data is inappropriate and not permissible.
- "Salami" publications. Dividing data, analysis, and presentation into "minimally publishable units" is a slippery slope, and can be used to extend one data set over several manuscripts. While this may be acceptable for clarity of presentation and focus on specific outcomes in different manuscripts, a motivation may also be to increase the publication list in an author's CV.
The latter is unethical and unacceptable.
Investigation of scientific misconduct. All cases of suspected misconduct will be investigated initially by the Editor-In-Chief and the Publications Committee of the American Society for Reproductive Medicine to determine if the evidence of misconduct is sufficient to proceed with a formal inquiry. If so, the author will be notified of the allegations in writing and will be asked to provide information useful to the investigation which may include but not be limited to access to all original data, notes, and copies of prior publications. The author's institution will be contacted, as well. Processing and publication of the manuscript will be delayed while the matter is under consideration and resolved. Confidentiality will be maintained and care taken to protect the rights and reputations of all concerned. The final decision on disposition of the paper and any sanctions against the author will be made by the Editor-In-Chief in concert with the Publications Committee.
Potential sanctions include, but may not be limited to: rejection of a manuscript in process; a letter of reprimand to the author with copy to the authors' institution(s); correction or retraction of the manuscript, including a statement in the print journal detailing the nature of the misconduct; and a ban on publication in the journal for two or more years.
Reviewers
Reviewers have the responsibility to objectively and fairly review the manuscript. If there is a conflict of interest or if the reviewer does not have the requisite expertise, then the manuscript should be immediately returned to the Editor for reassignment. Strict confidentiality is required during the review process. Written consent of the corresponding author is required if any portion of a manuscript is shared outside of the standard editorial process before the review is completed and accepted for publication.
OFFPRINTS
Offprints may be ordered by using the form that is sent by Elsevier Inc.
ANNOUNCEMENTS
Announcements regarding meetings, postgraduate courses, and symposia will be accepted for publication. For rates and to place an announcement, contact Ms. Traci Peppers, Classified Advertising Dept., Elsevier Inc., 360 Park Avenue South, New York, NY 10010; tel. 212-633-3766; FAX: 212-633-3820.
POLICY ON ADVERTISING
Advertisements are solicited and placed by the publisher without knowledge of the contents or order of the articles in the issue. The editors do not discuss journal content with the advertising staff or companies involved in purchasing advertising space. The Editorin- Chief reserves the right to reject any advertisements deemed inappropriate. However, the acceptance of advertisements does not imply endorsement or approval of the products or services by the journal or by the societies it represents.
REQUIREMENTS FOR SPECIFIC ARTICLE TYPES
Modern Trends
Modern Trends submissions should be review articles or topic overviews totaling approximately 3500 words in length. Manuscripts should be prepared according to the format of the journal. Manuscripts may be submitted online through EES.
Case reports, Techniques and Instrumentation, and Correspondence
Case reports should be succinct, informative, and limited to 1500 words of text (not including the running title, title page, capsule, or abstract). Include a 100-word case report summary in addition to your capsule and structured abstract. The title of your case report as well as the 100-word summary of your article will be published in the print issue. The full text of case reports is published online only.
Techniques and Instrumentation is limited to 1500 words and three illustrations (e.g., three figures OR two figures and one table). A Correspondence represents a precise insight and is not less of a contribution than an article in any other format. Correspondence submissions should be limited to 1500 of text and a maximum of one figure or one table. Include a 2-sentence narrative abstract in place of a structured abstract and do not include section headings.
Letters to the Editor
This section of the journal is set aside for critical comments directed to a specific article that has recently been published in the journal. Letters should be brief (500 words), double-spaced, and limited to a maximum of 5 citations. The letters and replies should be prepared according to journal format. These will only be published in the on-line (blog) version of the journal for 6 months and then stored in the archives which are accessible to readers on-line. Illustrative material is accepted only with permission of the Editor. Please include your complete mailing address, telephone and fax numbers, and e-mail address with your correspondence.
The Editor reserves the right to shorten letters, delete objectionable comments, and make other changes to comply with the style of the journal. Letters may be submitted online through EES or emailed directly to the editorial office at fertstert@asrm.org
Editor's Corner
Brief manuscripts written in editorial fashion on current social, political, and medical issues pertinent to reproductive medicine may be considered for this section. The manuscripts should be double- spaced and are limited to 1,000 to 1,500 words. Include a twosentence narrative abstract in place of the structured abstract.
Special Contributions
Special Contributions may take a variety of formats, such as review articles, commentaries, historical documents, and manuscripts on topics that are unusual for the journal. In general, shorter contributions should be organized the same way as correspondences or editorials, and reviews or longer manuscripts should be constructed as clinical articles. Please consult the editorial office for guidance on preparing your contribution for submission.
Images in Reproductive Medicine
Appropriate images to be submitted for this section include photographs of surgical or physical findings, photomicrographs, and ultrasound images with clinical correlates. The images must be original and previously unpublished. Most often, one or two pictures will be appropriate, although more may be acceptable. The images and manuscript must fit onto one journal page.
Manuscripts should be prepared according to the usual journal format. Prospective authors should submit three figures in a separate tiff, jpg, or eps file. Written materials should be original and brief (150 words), double-spaced, and limited to a maximum of 5 references. (Consider limiting to 2 editions or print in on-line only since these are rarely cited and may affect our impact factor) Please include a complete mailing address, telephone and fax numbers, and an e-mail address, if available, with the manuscript.
Submit articles online through EES. Questions may be addressed to: Richard J. Paulson, M.D., Department of Obstetrics and Gynecology, Women's and Children's Hospital, Room 8-K-9, LAC-USC Medical Center, 1240 North Mission Road, Los Angeles, California 90033 (Telephone: 323-226-3026; FAX: 323-226-2850; e-mail:rpaulson@usc.edu).
Monographs, Supplements, and Compilations
Supplements are paginated like a regular journal issue and consist of peer-reviewed original research. The cover is clearly identified with the volume and number, and the articles can be cited. Monographs are not peer reviewed, are not identified as part of the regular journal, are not paginated, and cannot be cited. Compilations are previously published journal articles with an index indicating where each article was published. All requests for publication of monographs, supplements, or compilations should be referred to the Publications Committee.
Updated June 2010
Editorial Board
Editor-in-Chief:
Alan H. DeCherney, MD
Bethesda, Maryland
Deputy Editor:
Richard Paulson, MD
Los Angeles, California
Associate Editor (Modern Trends):
Edward E. Wallach, MD
Luthersville, Maryland
Associate Editors:
Kurt Barnhart, MD, MSCE
Philadelphia, Pennsylvania
Douglas Carrell, PhD
Salt Lake City, Utah
Marcelle Cedars, MD
San Francisco, California
Owen Davis, MD
New York, New York
William Hurd, MD, MSc
Cleveland, Ohio
Dolores Lamb, PhD
Houston, Texas
Richard Legro, MD
Hershey, Pennsylvania
Craig Niederberger, MD
Chicago, Illinois
Steven Ory, MD
Margate, Florida
Alan Penzias, MD
Boston, Massachusetts
Catherine Racowsky, PhD
Boston, Massachusetts
Daniel Rappolee, PhD
Detroit, Michigan
Robert Schenken, MD
San Antonio, Texas
Editorial Board:
Ashok Agarwal, PhD
Cleveland, Ohio
Pedro Barri, MD, PhD
Barcelona, Spain
Susan H. Benoff, PhD
Manhasset, New York
Nasser Chegini, PhD
Gainesville, Florida
Jaques Cohen, PhD
West Orange, New Jersey
Christopher De Jonge, PhD
Minneapolis, Minnesota
Paul Devroey, MD, PhD
Brussels, Belgium
Thomas D'Hooghe, MD, PhD
Leuven, Belgium
Dominique de Ziegler, MD
Paris, France
Michael Diamond, MD
Detroit, Michigan
Esther Eisenberg, MD, MPH
Nashville, Tennessee
Bart Fauser, MD, PhD
Utrecht, Netherlands
Asgerally Fazleabas, PhD
Chicago, Illinois
Luca Gianaroli, MD
Bologna, Italy
William Gibbons, MD
Houston, Texas
Paul Gindoff, MD
Washington, DC
Mark Hamilton, MD
Aberdeen, United Kingdom
David Healy, PhD, MD
Melbourne, Australia
Mark Hornstein, MD
Boston, Massachusetts
Keith Isaacson, MD
Newton, Massachusetts
Stanley P. Leibo, PhD
New Orleans, Louisiana
Maurizio Macaluso, MD, DrPH
Atlanta, Georgia
Guillermo Marconi, MD
Buenos Aires, Argentina (Editor, South American Edition)
Kelle Moley, MD
St. Louis, Missouri
Camran Nezhat, MD
Stanford, California
Robert Norman, MD
Adelaide, Australia
Firuza Parikh, MD
Mumbai, India (Editor, Indian edition)
Elizabeth Puscheck, MD
Detroit, Michigan
Nanette Santoro, MD
Bronx, New York
William D. Schlaff, MD
Aurora, Colorado
Peter Schlegel, MD
New York, New York
Mark Sigman, MD
Providence, Rhode Island
Hugh Taylor, MD
New Haven, Connecticut
Robert Wild, MD, PhD, MPH
Oklahoma City, Oklahoma
Editorial Advisory Board
William Catherino, MD, PhD
Bethesda, MD
Anil Dubey, PhD
Washington, DC
David Frankfurter, MD
Washington, DC
Suheil Muasher, MD
Fairfax, VA
James Segars, MD
Bethesda, MD
Fady Sharara, M.D.
Reston, VA
Richard Sherins, MD
Washington, DC
Robert Stillman, MD
Rockville, MD
Eric Widra, MD
Washington, DC
Managing Editor:
Eric Steinmehl
Birmingham, Alabama
Editorial Assistant:
Nancy Kucik
Birmingham, Alabama
Former Editors
Pendleton Tompkins, MD
Editor 1950-1952
M. Edward Davis, MD
Editor 1953-1969
Luigi Mastroianni, Jr., MD
Editor 1970-1975
Roger D. Kempers, MD
Editor 1976-1997
|
刊名字顺( Alphabetical List of Journals):
返回页首 